#news #biotech Idera’s TLR9 drug flunks melanoma phase 3, tanking stock

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Idera’s TLR9 drug flunks melanoma phase 3, tanking stock .Idera’s TLR9 drug flunks melanoma phase 3, tanking stock
ntaylor
Fri, 03/19/2021 – 06:17

from FierceBiotech: Biotech https://ift.tt/3s2ybsT